| Entry |
|
|---|
| Name |
Elvucitabine (USAN/INN) |
|---|
| Formula |
C9H10FN3O3
|
|---|
| Exact mass |
227.0706
|
|---|
| Mol weight |
227.19
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG01440 Arabinofuranosyl type antiviral
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
|
|---|
| Efficacy |
Antiviral, Reverse transcriptase inhibitor |
|---|
| Target |
HIV-1 reverse transcriptase [KO: K24802] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D03981 Elvucitabine
DG01440 Arabinofuranosyl type antiviral
D03981 Elvucitabine
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
D03981 Elvucitabine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D03981 Elvucitabine (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 16
1 C1y C 18.5187 -17.3457
2 N4y N 19.8402 -16.9247
3 O2x O 17.3785 -16.5272
4 C2x C 18.0743 -18.6848
5 C8y C 21.0601 -17.5900
6 C8x C 19.8266 -15.5182
7 C1y C 16.2440 -17.3457
8 C2x C 16.6768 -18.6848
9 N5x N 22.2683 -16.8864
10 O5x O 21.0686 -18.9845
11 C8y C 21.0308 -14.7973
12 C1b C 14.9107 -16.9247
13 C8y C 22.2531 -15.4872
14 X F 21.0085 -13.3939
15 O1a O 13.8698 -17.8544
16 N1a N 23.4602 -14.7737
BOND 17
1 1 2 1 #Down
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 2
8 5 9 1
9 5 10 2
10 6 11 2
11 7 12 1 #Down
12 9 13 2
13 11 14 1
14 12 15 1
15 7 8 1
16 11 13 1
17 13 16 1
|
|---|
